With its cheap copies, India turned into the pharmacy of the world. But it’s time to move beyond exporting vanilla generics and on to manufacturing complex drugs
Read More
Cooperation on drug matters is expected to curb the illicit traffic of narcotic drugs, psychotropic substances and precursor chemicals in the two countries
Read More
The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026
Read More
70 per cent slash in current market price of orthopaedic knee implants
Read More
Biocon will re-submit the applications for breast cancer drug Trastuzumab and Pegfilgrastim, which cuts infection risk in patients undergoing chemotherapy, after the European Medicines Agency completes the inspection
Read More
No lapses can be greater than the loop holes in the country’s medicine making and distribution market
Read More
The net loss was 4.25 billion rupees ($66 million) in the three months ending on June 30, compared with a profit of 20.34 billion rupees a year earlier
Read More
Revenue from South Africa, Cipla's third largest market, rose 21 per cent to Rs 4.88 billion compared with last year while Europe revenues climbed 33 per cent to Rs 1.58 billion
Read More
India is one of the world's largest producers of generic pharmaceuticals and it is important for NSF International to be here
Read More
The deal has won the approval of the Competition Commission of India (CCI) and India's Foreign Investment Promotion Board (FIPB) in the last few months, but some in the government have expressed concerns
Read More
